Dividends
Yum Brands reports mixed results as Pizza Hut and KFC same-store sales fall
A sign is posted in front of a Taco Bell restaurant on May 01, 2024 in Richmond, California. Justin Sullivan | Getty Images Yum Brands on Tuesday reported a mixed quarter as both Pizza Hut and KFC reported declining same-store sales. Shares of the company fell less than 1% in premarket trading. Here’s what the […]
Read More
Oil giant Saudi Aramco’s second-quarter profit dips 3% on lower crude production volumes
A 3D printed natural gas pipeline on Feb. 8, 2022. Dado Ruvic | Reuters Saudi state oil giant Aramco reported $29.1 billion in net profit for the second quarter, a dip of just over 3% from the same period last year as crude production volumes remained low. Aramco reaffirmed its second-quarter base dividend of $20.3 […]
Read More
Stocks making the biggest moves premarket: Exxon Mobil, Intel, Apple, Snap, Amazon and more
Check out the companies making headlines before the bell. Exxon Mobil — The energy giant reported a stronger-than-expected profit for the second quarter amid record production in Guyana and the Permian Basin. Earnings per share came in at $2.14, beating an LSEG forecast of $2.01 per share. Shares were up slightly in the premarket. Intel […]
Read More
Daily Open: U.S. stocks fall; 10-year Treasury yield drops below 4%; Apple beats Street while Amazon falters
A trader works during the closing bell at the New York Stock Exchange (NYSE) on March 17, 2020 at Wall Street in New York City. Johannes Eisele | Afp | Getty Images This report is from today’s CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they […]
Read More
Stocks making the biggest moves after hours: Apple, Amazon, Intel, Snap and more
Customers are trying on and learning about Apple Vision Pro headsets at an Apple store in Shanghai, China, on July 22, 2024. Costfoto | Nurphoto | Getty Images Check out the companies making headlines in extended trading: Intel — The chip stock sank 17%. Intel said it would suspend its dividend in the fiscal fourth […]
Read More
Carvana beats Wall Street’s second-quarter expectations, guides toward record year
In an aerial view, a sign is posted on the exterior of a Carvana car vending machine on July 19, 2023 in Daly City, California. Justin Sullivan | Getty Images Shares of Carvana jumped as much as 14% during after-hours trading Wednesday as the company topped Wall Street’s expectations for the second quarter and disclosed […]
Read More
Stocks making the biggest moves premarket: Pinterest, Match Group, Advanced Micro Devices and more
Check out the companies making headlines before the bell: DuPont — Shares popped 5% on the back of better-than-expected results in the second quarter. The chemical maker earned 97 cents per share, excluding certain items, on revenue of $3.17 billion. Analysts expected a profit of 85 cents per share on revenue of $3.05 billion, according […]
Read More
Stocks making the biggest moves midday: JetBlue, Sprouts Farmers Market, Varonis Systems and more
Check out the companies making headlines in midday trading: JetBlue — The airline soared almost 20% after reporting second-quarter earnings that beat analysts’ expectations . The New York City-based carrier posted adjusted earnings of 8 cents per share, excluding one-time items, compared to analysts’ estimated loss of 11 cents per share, according to LSEG. Revenue […]
Read More
Procter & Gamble earnings beat estimates, but quarterly sales disappoint
Procter & Gamble on Tuesday reported mixed quarterly results, but the company’s volume increased for the first time in more than two years. Volume excludes pricing, making the metric a more accurate reflection of demand than sales. Over the last several years, P&G’s price hikes across its portfolio, from diapers to detergent, fueled its sales […]
Read More
Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs
Kena Betancur | Corbis News | Getty Images Pfizer on Thursday reported second-quarter revenue and adjusted earnings that blew past expectations and raised its full-year outlook, benefiting from its broad cost-cutting program, better-than-expected sales of its Covid antiviral pill Paxlovid and strong non-Covid product sales. The company now expects to book adjusted earnings of $2.45 to $2.65 […]
Read More